Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001117120-04-000003
Filing Date
2004-06-01
Accepted
2004-06-01 15:28:18
Documents
1
Period of Report
2004-05-27

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 8443
  Complete submission text file 0001117120-04-000003.txt   10087
Mailing Address
Business Address 8725 W HIGGINS RD STE 290 CHICAGO IL 60631
ARCH VENTURE FUND V LP (Reporting) CIK: 0001117120 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50743 | Film No.: 04841192

Mailing Address 790 MEMORIAL DR CAMBRIDGE MA 02139
Business Address 790 MEMORIAL DR CAMBRIDGE MA 02139 6172520700
ALNYLAM PHARMACEUTICALS INC (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661
SIC: 2834 Pharmaceutical Preparations